Jaguar Health, Inc.
Develops plant-based prescription medicines for human and animal GI diseases.
JAGX | US
Overview
Corporate Details
- ISIN(s):
- US47010C6075
- LEI:
- Country:
- United States of America
- Address:
- 200 PINE STREET SUITE 400, 94104 SAN FRANCISCO
- Website:
- https://jaguar.health/
- Sector:
- Manufacturing
Description
Jaguar Health, Inc. is a commercial-stage pharmaceutical company that discovers, develops, and commercializes novel, proprietary, plant-based prescription medicines for both human and animal health. The company's primary focus is on addressing gastrointestinal (GI) diseases. Its core product, crofelemer, is a botanical drug sustainably derived from the Croton lechleri tree. For human health, crofelemer is in a Phase 3 clinical trial (OnTarget) for the preventative treatment of cancer therapy-related diarrhea and is also being studied for rare diseases like short bowel syndrome. In the animal health market, the company commercializes Canalevia-CA1, a prescription treatment for chemotherapy-induced diarrhea in dogs. Jaguar Health's pipeline spans multiple stages of development, leveraging its expertise in sustainably derived, plant-based therapeutics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Jaguar Health, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Jaguar Health, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Jaguar Health, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||